VWWMG
ABEO icon

Vermillion & White Wealth Management Group’s Abeona Therapeutics ABEO Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-370
Closed -$1.95K – 69
2025
Q4 		$1.95K Hold
370
– – ﹤0.01% 497
2025
Q3 		$1.95K Hold
370
– – ﹤0.01% 502
2025
Q2 		$2.1K Buy
+370
New +$2.11K ﹤0.01% 459

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vermillion & White Wealth Management Group's ABEO Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Abeona Therapeutics (ABEO) in Q1 2026, closing a stake of 370 shares — an estimated $1.95K sold.

Vermillion & White Wealth Management Group first reported a position in ABEO in Q2 2025 and held it in 3 quarters. The position peaked at $2.1K in Q2 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining Abeona Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 370 Abeona Therapeutics shares in Q1 2026, an estimated $1.95K.
  • Vermillion & White Wealth Management Group first reported a position in Abeona Therapeutics in Q2 2025 and held it in 3 quarters.
  • Vermillion & White Wealth Management Group's Abeona Therapeutics position peaked at $2.1K in Q2 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.